Order Article Reprints

Jovanović N, Mitrović T, Cvetković VJ, Tošić S, Vitorović J, Stamenković S, Nikolov V, Kostić A, Vidović N, Krstić M, et al. The Impact of MGMT Promoter Methylation and Temozolomide Treatment in Serbian Patients with Primary Glioblastoma. Medicina. 2019; 55(2):34. https://doi.org/10.3390/medicina55020034

Jovanović, Nikola, Tatjana Mitrović, Vladimir J. Cvetković, Svetlana Tošić, Jelena Vitorović, Slaviša Stamenković, Vesna Nikolov, Aleksandar Kostić, Nataša Vidović, Miljan Krstić, and et al. 2019. "The Impact of MGMT Promoter Methylation and Temozolomide Treatment in Serbian Patients with Primary Glioblastoma" Medicina 55, no. 2: 34. https://doi.org/10.3390/medicina55020034

Jovanović, N., Mitrović, T., Cvetković, V. J., Tošić, S., Vitorović, J., Stamenković, S., Nikolov, V., Kostić, A., Vidović, N., Krstić, M., Jevtović-Stoimenov, T., & Pavlović, D. (2019). The Impact of MGMT Promoter Methylation and Temozolomide Treatment in Serbian Patients with Primary Glioblastoma. Medicina, 55(2), 34. https://doi.org/10.3390/medicina55020034